Indiana University Cancer center

Indianapolis, Indiana 46206

1 studies enrolling now · 288 studies all time

What they study most

Accelerated Phase Chronic Myelogenous Leukemia, Acute Disease, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Adult Brain Malignant Hemangiopericytoma, Adult Central Nervous System Germ Cell Tumor, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Malignant Meningioma, Adult Rhabdomyosarcoma

Studies at this site

• A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) — Recruiting now
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) — Running, not enrolling
• A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC — Running, not enrolling
• N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation — Completed
• N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma — Completed
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — Completed
• Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma — Completed
• Investigation of Genetic Determinants of Capecitabine Toxicity — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis — Stopped early
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma — Completed
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer — Completed
• Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer — Completed
• Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia — Completed
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ — Stopped early
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract — Completed
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors — Completed
• PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer — Completed
• Diagnostic Study of Patients With Stage I Testicular Cancer — Completed
• High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis — Completed
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia — Completed
• Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia — Completed
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer — Completed
• Methylphenidate in Treating Patients With Melanoma — Completed
• Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer — Completed
• Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer — Completed
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer — Completed
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas — Completed
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer — Completed
• Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus — Completed
• Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer — Completed
• S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer — Completed
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ — Completed
• Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) — Completed
• Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer — Completed
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer — Completed
• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
• Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer — Completed
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors — Completed
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed
• Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma — Completed
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer — Completed
• Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors — Completed
• Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors — Completed
• A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial — Completed
• Trial of Dasatinib in Advanced Sarcomas — Completed
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed